Research map: Immunotherapy-Associated Autoimmune Hemolytic Anemia: Two Case Reports and a Literature Review

Back to the article

Papers in this map

  1. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline · Julie Renee Brahmer · 2018 · 3767 citations · Cited by this paper
  2. Clinical Features, Treatment, and Outcomes of Nivolumab-induced Autoimmune Hemolytic Anemia · 2026 · Related
  3. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial · Domenica Lorusso · 2024 · 399 citations · Cited by this paper
  4. A Novel Imidazoquinoline With TLR 7/8, STING, and Inflammasome Activity Demonstrates Antitumor Efficacy in Mouse Melanoma and Neu-Driven Mammary Adenocarcinoma · 2025 · Related
  5. Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study · Nicolas Delanoy · 2018 · 301 citations · Cited by this paper
  6. Clinical Features, Treatment, and Outcomes of Sintilimab-Induced Myocarditis · 2025 · Related
  7. The diagnosis and management of primary autoimmune haemolytic anaemia · Quentin A. Hill · 2016 · 277 citations · Cited by this paper
  8. Immunoregulatory Cyclophilin A Reprograms the Tumor Immune Microenvironment by Changing the Activation and Exhaustion Profile of T Cells and NK Cells in the Model of Melanoma B16 in Vivo · 2025 · Related
  9. Hematologic Complications of Immune Checkpoint Inhibitors · Elizabeth J. Davis · 2019 · 178 citations · Cited by this paper
  10. High Expression of Calreticulin Affected the Tumor Microenvironment and Correlated With Worse Prognosis in Patients With Triple-Negative Breast Cancer · 2025 · Related
  11. Hematologic complications of immune checkpoint inhibitors · Michael H. Kroll · 2021 · 144 citations · Cited by this paper
  12. Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels · 2025 · Related
  13. Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review · Georges E. Tanios · 2018 · 96 citations · Cited by this paper
  14. Synergistic Effect of Anti-PD-L1 Treatment and CD8+ T-Cell Activating Nanotherapy in Pancreatic Ductal Adenocarcinoma Evaluated via 3D Mathematical Modeling · 2025 · Related
  15. Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors · Rebecca Karp Leaf · 2019 · 85 citations · Cited by this paper
  16. DLGAP5 Drives Lung Cancer Progression: Combined Bioinformatics and Clinical Prognostic Analysis · 2026 · Related
  17. Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia · Roser Calvo · 2019 · 58 citations · Cited by this paper
  18. Design of Therapeutic Vaccines Based on Antigen Epitopes of α-9 HPV E6 in Sichuan · 2025 · Related
  19. Immunotherapy-associated Autoimmune Hemolytic Anemia · Steven Ray Hwang · 2022 · 22 citations · Cited by this paper
  20. Integrated Genomic Analysis Identifies Clinically Relevant Molecular Subtypes and Disulfidptosis-Related Prognostic Signature of Gastric Cancer · 2025 · Related

Source: OpenAlex (CC0)